☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Interchangeable
Amgen Seeks Interchangeable Status for Its Amjevita (biosimilar, adalimumab)
November 8, 2021
Pfizer Seeks to Obtain Interchangeable Status for Abrilada (biosimilar, adalimumab)
November 4, 2021
The US FDA Released Draft Guidelines for Proposed Biosimilar or Proposed Interchangeable Biosimilars
February 7, 2020
The US FDA Draft New Guidelines for Proposed Biosimilars and Interchangeable Insulins
November 25, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
